Comparative analysis of Helicobacter DNAs and biliary pathology in patients with and without hepatobiliary cancer.
Several Helicobacter species have recently been isolated from the bile and hepatobiliary systems of murine species, and are well recognized as a pathogen of the hepatobiliary disorder. This study was planned to investigate whether Helicobacter species possess a causative potential for human hepatobiliary disease, especially for hepatobiliary carcinogenesis. Bile and hepatobiliary tissue samples from 19 patients with hepatobiliary cancer and 19 patients with benign biliary diseases were subjected to polymerase chain reaction analyses for the detection of Helicobacter DNAs. Using a proliferating cell nuclear antigen (PCNA) staining technique, we also investigated the biliary epithelial cell kinetics with special reference to the presence of Helicobacter DNAs in the hepatobiliary system. We found that Helicobacter DNAs were positive in 10 (52.6%) of the 19 patients with hepatobiliary cancer. The incidence was significantly higher than that (15.7%) in the benign cases (P = 0.03). The PCNA labeling index in the biliary epithelium in Helicobacter DNA-positive patients was statistically higher than that in Helicobacter DNA-negative ones, regardless of whether the patient was suffering from hepatobiliary cancer and/or biliary inflammation. A close correlation between the presence of Helicobacter DNAs and an elevation of the PCNA labeling index in the biliary epithelium was demonstrated by multiple regression analysis. Our findings suggest that Helicobacter species may play a role in the pathogenesis of hepatobiliary cancer through an acceleration of biliary cell kinetics.
Fukuda
Kenzo
K
Department of Surgery II, Nagasaki University School of Medicine, Nagasaki, Japan. kenzofukuda-gi@umin.ac.jp
Kuroki
Tamotsu
T
Tajima
Yoshitsugu
Y
Tsuneoka
Noritsugu
N
Kitajima
Tomoo
T
Matsuzaki
Sumihiro
S
Furui
Junichiro
J
Kanematsu
Takashi
T
D000236:Adenoma / Q000737:chemistry / Q000382:microbiology / Q000473:pathology; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014670:Ampulla of Vater; D000951:Antigens, Neoplasm / Q000032:analysis; D001650:Bile Duct Neoplasms / Q000737:chemistry / Q000382:microbiology / Q000473:pathology; D001661:Biliary Tract Neoplasms / Q000737:chemistry / Q000382:microbiology* / Q000473:pathology; D015415:Biomarkers; D002277:Carcinoma / Q000737:chemistry / Q000382:microbiology / Q000473:pathology; D002453:Cell Cycle; D002769:Cholelithiasis / Q000378:metabolism / Q000382:microbiology; D003138:Common Bile Duct Neoplasms / Q000737:chemistry / Q000382:microbiology / Q000473:pathology; D004269:DNA, Bacterial / Q000032:analysis*; D005260:Female; D005706:Gallbladder Neoplasms / Q000737:chemistry / Q000382:microbiology / Q000473:pathology; D016998:Helicobacter / Q000235:genetics / Q000302:isolation & purification* / Q000472:pathogenicity; D016480:Helicobacter pylori / Q000235:genetics / Q000302:isolation & purification / Q000472:pathogenicity; D006801:Humans; D008113:Liver Neoplasms / Q000737:chemistry / Q000382:microbiology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009928:Organ Specificity; D016133:Polymerase Chain Reaction; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis
D000951:Antigens, Neoplasm; D015415:Biomarkers; D004269:DNA, Bacterial; D018809:Proliferating Cell Nuclear Antigen